Leo Pharma

2 articles

Leo Pharma Considers Postponing IPO Amid Market Turmoil

Danish drugmaker Leo Pharma is considering delaying its planned IPO until 2027 due to ongoing global financial market turmoil. A company spokesperson declined to comment on the potential delay.

reuters · 2026-11-06 04:40

Europe's Equity Bankers Bet on Capex Wave to Ride Out IPO Slump

European companies raised $88.7 billion in H1 2026 to fund AI and energy infrastructure, offsetting an IPO slump. Key firms including RWE and Leo Pharma utilized elevated stock prices for capital need

bloomberg · 2026-07-06 05:00